ZRANB1 and hepatocellular carcinoma: Conversely, DUB TRAF-binding domain (Trabid) can promote the degradation of Twist1 by removing K63-linked ubiquitin chains, leading to its degradation and EMT inhibition in hepatocellular carcinoma (HCC) 153.